Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

Summary Chronic anovulation, polycystic ovarian morphology and hyperandrogenism are the diagnostic criteria for polycystic ovary syndrome (PCOS). Metabolic disturbances are more common in PCOS women who are prone to develop metabolic syndrome and to present higher levels of some cardiovascular disea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical practice (Esher) 2009-01, Vol.63 (1), p.160-169
Hauptverfasser:	Soares, G. M., Vieira, C. S., De Paula Martins, W., Dos Reis, R. M., De Sá, M. F. S., Ferriani, R. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Birth control Cardiovascular system Contraceptives, Oral, Combined - adverse effects Contraceptives, Oral, Combined - therapeutic use Epidemiologic Methods Female Female genital diseases General aspects Gynecology. Andrology. Obstetrics Humans Impact analysis Medical disorders Medical sciences Metabolic Diseases - chemically induced Metabolic syndrome Middle Aged Non tumoral diseases Polycystic Ovary Syndrome - drug therapy Reproductive system Weight Gain - drug effects Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!